EMA Withdrawn: Tikosyn (dofetilide) — Pfizer Limited

View source ↗

Summary

Tikosyn (dofetilide) has been withdrawn in the EU by Pfizer Limited, with the medicinal product no longer authorized for use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Tikosyn (dofetilide)

Snippet

Status: Withdrawn. Therapeutic area: Atrial Fibrillation;Atrial Flutter. MAH: Pfizer Limited. Decision date: 31/12/2009